MAPT and Alzheimer disease: Blunt impact mTBI increases the risk of chronic development of tau-dependent neuropathology, a hallmark of neurodegenerative diseases including Alzheimer's disease (AD) or chronic traumatic encephalopathy (CTE) (118).